Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118056133 | 11805613 | 3 | F | 20151111 | 20160705 | 20151207 | 20160714 | EXP | PT-ALEXION PHARMACEUTICALS INC-A201504527 | ALEXION | 37.43 | YR | M | Y | 89.00000 | KG | 20160714 | OT | PT | PT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118056133 | 11805613 | 1 | PS | SOLIRIS | ECULIZUMAB | 1 | Intravenous (not otherwise specified) | 900 MG, QW | P0003704 | 125166 | 900 | MG | CONCENTRATE FOR SOLUTION FOR INFUSION | /wk | |||||
| 118056133 | 11805613 | 2 | SS | SOLIRIS | ECULIZUMAB | 1 | Intravenous (not otherwise specified) | 900 MG, QW | P0003704 | 125166 | 900 | MG | CONCENTRATE FOR SOLUTION FOR INFUSION | /wk | |||||
| 118056133 | 11805613 | 3 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | Oral | 60 UNK, UNK | 0 | ||||||||||
| 118056133 | 11805613 | 4 | C | CLONIDINE. | CLONIDINE | 1 | Oral | 0.3 UNK, UNK | 0 | ||||||||||
| 118056133 | 11805613 | 5 | C | NIFEDIPINE. | NIFEDIPINE | 1 | Oral | 120 UNK, UNK | 0 | ||||||||||
| 118056133 | 11805613 | 6 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 60 UNK, UNK | 0 | ||||||||||
| 118056133 | 11805613 | 7 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | Oral | 40 MG, UNK | 0 | 40 | MG | ||||||||
| 118056133 | 11805613 | 8 | C | MYCOPHENOLATE MOFETIL. | MYCOPHENOLATE MOFETIL | 1 | Unknown | 0 | |||||||||||
| 118056133 | 11805613 | 9 | C | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Unknown | 0 | |||||||||||
| 118056133 | 11805613 | 10 | C | METILPREDNISOLONA /00049601/ | 2 | Unknown | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 118056133 | 11805613 | 1 | Glomerulonephritis |
| 118056133 | 11805613 | 2 | Off label use |
| 118056133 | 11805613 | 3 | Glomerulonephritis acute |
| 118056133 | 11805613 | 4 | Hypertension |
| 118056133 | 11805613 | 5 | Hypertension |
| 118056133 | 11805613 | 6 | Hypertension |
| 118056133 | 11805613 | 7 | Gastritis prophylaxis |
| 118056133 | 11805613 | 8 | Immunosuppression |
| 118056133 | 11805613 | 9 | Immunosuppression |
| 118056133 | 11805613 | 10 | Immunosuppression |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 118056133 | 11805613 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 118056133 | 11805613 | Leukocytosis | |
| 118056133 | 11805613 | Off label use |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 118056133 | 11805613 | 1 | 20151111 | 0 | ||
| 118056133 | 11805613 | 2 | 20151126 | 0 | ||
| 118056133 | 11805613 | 3 | 20151016 | 0 | ||
| 118056133 | 11805613 | 4 | 20151015 | 0 | ||
| 118056133 | 11805613 | 5 | 20151015 | 0 | ||
| 118056133 | 11805613 | 6 | 20151015 | 0 | ||
| 118056133 | 11805613 | 7 | 20151016 | 0 |